SymBio Pharmaceuticals - At the turning point
SymBio is approaching a major transition as it prepares to begin internal marketing of its lead product Treakisym (bendamustine), launch new liquid...
106 Views
SymBio Pharmaceuticals - Top-line data from registrational DLBCL study
SymBio will be presenting data at the European Society of Hematology (EHA) meeting from its pivotal study in Japan of Treakisym (bendamustine) in...
96 Views
SymBio Pharmaceuticals - Top-line data from registrational DLBCL study
SymBio will be presenting data at the European Society of Hematology (EHA) meeting from its pivotal study in Japan of Treakisym (bendamustine) in...
80 Views
SymBio Pharmaceuticals - Treakisym label expansion submitted
SymBio announced on 11 May 2020 that it submitted an application to expand the label for Treakisym in Japan to include the treatment of relapsed...
52 Views
SymBio Pharmaceuticals - Treakisym label expansion submitted
SymBio announced on 11 May 2020 that it submitted an application to expand the label for Treakisym in Japan to include the treatment of relapsed...
42 Views